Raynaud phenomenon is a condition where small blood vessels in your fingers and toes temporarily overreact to cold or stress, clamping down so tightly that blood flow nearly stops. It affects roughly 5% of the general population, and the hallmark sign is fingers that turn white, then blue, then red as blood flow cuts off and eventually returns. Most cases are harmless and manageable with simple lifestyle changes, but in some people Raynaud’s signals an underlying autoimmune disease that needs attention.
What Happens Inside Your Blood Vessels
When anyone steps into cold air, blood vessels in the fingers and toes naturally narrow to conserve heat. In Raynaud phenomenon, that response is dramatically exaggerated. The smooth muscle wrapped around tiny arteries in the digits contracts far more than it should, choking off blood supply for minutes or sometimes longer.
The process starts when cold temperatures trigger your mitochondria, the energy-producing structures inside muscle cells lining your blood vessels, to act as temperature sensors. They release molecules called reactive oxygen species, which set off a chain reaction that pulls specific receptors to the surface of those muscle cells. These receptors respond to the stress hormone norepinephrine by squeezing the vessel shut. In most of the body, this is a controlled process. In the fingers and toes, there’s a much higher density of these cold-sensitive receptors, which is why those areas bear the brunt of an attack.
The Three-Phase Color Change
A classic Raynaud attack follows a predictable pattern of three color stages, though not everyone experiences all three. First, the affected fingers or toes turn white as blood flow stops entirely. This is the ischemic phase, and the digits often feel numb or cold. Next comes a blue or purplish color as the small amount of trapped blood loses its oxygen. Finally, when the vessels relax and blood rushes back in, the skin flushes red. This reperfusion phase often brings throbbing, tingling, or a burning sensation.
Attacks typically last 15 to 20 minutes but can stretch longer. They’re most commonly triggered by cold exposure (even reaching into a freezer or holding an iced drink), but emotional stress can set them off too. The fingers are the most frequent target, though toes, ears, and the tip of the nose can also be affected.
Primary vs. Secondary Raynaud’s
Raynaud phenomenon falls into two categories, and the distinction matters because treatment and outlook differ significantly.
Primary Raynaud’s has no identifiable underlying cause. It tends to appear in early adulthood, is more common in women, and often runs in families. Estrogen levels appear to play a role, which helps explain why women are affected at higher rates (about 5.7% of women compared to 4.1% of men in pooled population studies). Primary Raynaud’s is generally mild. Attacks are uncomfortable but don’t cause lasting tissue damage.
Secondary Raynaud’s develops alongside another condition, most often an autoimmune or connective tissue disease. The most commonly associated conditions include scleroderma, lupus, Sjögren syndrome, rheumatoid arthritis, and polymyositis. It can also be linked to thyroid disorders, blood disorders, arterial disease like atherosclerosis, and pulmonary hypertension. Certain medications and repetitive trauma (such as using vibrating tools for years) can trigger it as well. Secondary Raynaud’s tends to appear later in life and carries a higher risk of complications, including finger ulcers and tissue loss.
How Raynaud’s Is Diagnosed
Diagnosis starts with your description of symptoms, particularly the characteristic color changes in response to cold or stress. There’s no single blood test that confirms Raynaud’s, but doctors use a combination of tools to determine whether you have the primary or secondary form.
One key test is nailfold capillaroscopy, where a doctor examines the tiny blood vessels at the base of your fingernails under magnification. In primary Raynaud’s, these capillaries look normal. Abnormal patterns, such as enlarged, distorted, or missing capillaries, suggest a secondary cause and often point toward connective tissue disease. Blood tests for antinuclear antibodies (ANA) help screen for autoimmune conditions. A diagnosis of primary Raynaud’s requires normal capillaroscopy, no signs of tissue damage on physical exam, no history of connective tissue disease, and a negative or very low ANA result.
New onset of Raynaud’s later in adulthood, particularly after age 30 or 40, warrants closer investigation for an underlying condition.
Managing Symptoms Day to Day
For most people with primary Raynaud’s, lifestyle adjustments are the first and sometimes only treatment needed. The goal is straightforward: keep your core body temperature up and avoid the triggers that set off attacks.
Dressing in layers and wearing insulated gloves or mittens is the foundation. Wool-lined or battery-heated gloves can make a real difference in cold climates. Heavy socks and hand warmers help too. Beyond clothing, keeping your whole body warm matters more than just protecting your hands, because your body restricts blood flow to extremities when your core temperature drops. Running warm water over your hands during an attack can help end it faster. Avoiding smoking is critical, as nicotine constricts blood vessels and worsens symptoms significantly.
Medication Options
When lifestyle changes aren’t enough, calcium channel blockers are the most widely used first-line medication. These drugs relax the smooth muscle in blood vessel walls, making it harder for them to clamp down during an attack. They can reduce both the frequency and severity of episodes. Treatment typically starts at a low dose and increases gradually based on how well you tolerate it.
For people with severe or secondary Raynaud’s that doesn’t respond to calcium channel blockers, doctors sometimes prescribe medications originally developed for erectile dysfunction. These drugs work by prolonging the natural relaxation signals in blood vessel walls. A Cochrane review of eight studies found they reduce the number of attacks by about three per week and shorten each attack by roughly five minutes. Perhaps more importantly for people with secondary Raynaud’s, those with digital ulcers were more than twice as likely to see their ulcers heal compared to placebo. Side effects are generally mild, though dropout rates were somewhat higher than with placebo (up to 20% vs. 2 to 4%).
When Raynaud’s Causes Tissue Damage
In primary Raynaud’s, permanent tissue damage is rare. Secondary Raynaud’s, particularly when associated with scleroderma, is a different story. The blood vessel narrowing can become severe enough to cause digital ulcers, which are painful sores on the fingertips that heal slowly and are prone to infection.
In a large registry of over 4,600 scleroderma patients with digital ulcers, about 18% had experienced gangrene at some point, and roughly 6% had active gangrene at the time of enrollment. The strongest predictor of developing gangrene was having had it before, which increased the risk more than fourfold. Smoking (current or former) nearly doubled the risk, and having three or more finger ulcers at once also significantly raised the likelihood of progression. These numbers underscore why aggressive management of secondary Raynaud’s, and absolute avoidance of smoking, is so important in people with connective tissue diseases.
Primary Raynaud’s Outlook
If you’ve been diagnosed with primary Raynaud’s, the long-term outlook is very good. The condition is a nuisance, not a danger. Attacks may become less frequent with age in some people. The main priority is staying aware of your triggers and having a plan for cold weather. A small percentage of people initially diagnosed with primary Raynaud’s will eventually develop an autoimmune condition, which is one reason periodic follow-up with your doctor is worthwhile, especially if your symptoms change or worsen over time.